Effects of sitagliptin on the serum creatinine in Japanese type 2 diabetes

Diabetes Res Clin Pract. 2015 Jun;108(3):e42-5. doi: 10.1016/j.diabres.2015.03.008. Epub 2015 Mar 16.

Abstract

We found a slight elevation of serum creatinine in the subjects treated with sitagliptin for 2 years and a correlation between creatinine elevation and HbA1c reduction. These results suggest that creatinine elevation is associated with activation of incretin, most possibly with up-regulation of diuretic activity of GLP-1.

Keywords: Creatinine; Dipeptidyl peptidase-4 (DPP-4) inhibitor; HbA1c; Sitagliptin.

Publication types

  • Multicenter Study
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Creatinine / blood*
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / ethnology
  • Dipeptidyl-Peptidase IV Inhibitors / therapeutic use*
  • Female
  • Glucagon-Like Peptide 1 / blood
  • Glycated Hemoglobin / metabolism
  • Humans
  • Japan / epidemiology
  • Male
  • Middle Aged
  • Retrospective Studies
  • Sitagliptin Phosphate / therapeutic use*

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Glycated Hemoglobin A
  • hemoglobin A1c protein, human
  • Glucagon-Like Peptide 1
  • Creatinine
  • Sitagliptin Phosphate